Psoriasis therapeutic market

pharma-news-for-sarepta-imcheck-redhill

Jul 22, 2025

Sarepta Therapeutics Pauses ELEVIDYS Shipments in U.S. After FDA Intervention Over Patient Deaths; ImCheck’s ICT01 Granted FDA Orphan Drug Designation for Acute Myeloid Leukemia; RedHill Biopharma Gets Positive FDA Feedback on RHB-204 for Crohn’s Disease Approval Pathway; FDA Grants Fast Track Designation to ProMIS Neurosciences’ PMN310 for Alzheimer’s Disease; Oruka Therapeutics Receives IND Clearance for Phase IIa Trial of ORKA-001 in Psoriasis

Latest Developments in the US Psoriasis Treatment Market

Apr 19, 2024

Revolutionizing Psoriasis Treatment: Advancements in the US Market

Pharma News

Aug 27, 2019

Zogenix acquires Modis Therapeutics; Amgen buys Otezla; CRISPR slows down the Breast cancer rate

Psoriasis Pipeline

Aug 14, 2019

Psoriasis Pipeline: Upcoming Psoriasis Treatments

Psoriasis Therapy Market

Aug 12, 2019

Psoriasis Therapy Market Size 

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper